BioAtla, Inc. — Director's Dealing 2023

Jun 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2023-06-14

Reporting Person: Smith Scott Andrew (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-14	Stock Option (Right to Buy)	$3.55	A	50000	Acquired	2033-06-14	Common Stock (50000)	Direct
2023-06-14	Stock Option (Right to Buy)	$3.55	A	5895	Acquired	2033-06-14	Common Stock (5895)	Direct

Footnotes

F1: 100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 14, 2024 or (b) the day before the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date.

F2: Fully vested and exercisable.